Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 134, Issue 2, Pages 561-567
Publisher
Springer Nature
Online
2012-05-19
DOI
10.1007/s10549-012-2092-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes
- (2011) Sandrine Boyault et al. BREAST CANCER RESEARCH AND TREATMENT
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- Molecular Stratification of Triple-Negative Breast Cancers
- (2011) C. M. Perou ONCOLOGIST
- Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer
- (2010) Alfonso Sánchez-Muñoz et al. BMC CANCER
- EGFR expression and gene copy number in triple-negative breast carcinoma
- (2010) Berrak Gumuskaya et al. CANCER GENETICS AND CYTOGENETICS
- Epidermal Growth Factor Receptor in Triple-Negative and Basal-Like Breast Cancer
- (2010) Monika L. Burness et al. CANCER JOURNAL
- Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases
- (2010) Yihua Sun et al. JOURNAL OF CLINICAL ONCOLOGY
- Diverse somatic mutation patterns and pathway alterations in human cancers
- (2010) Zhengyan Kan et al. NATURE
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers
- (2009) Sharon Nofech-Mozes et al. BREAST CANCER RESEARCH AND TREATMENT
- Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors
- (2009) Radharani Gollamudi et al. INVESTIGATIONAL NEW DRUGS
- EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer
- (2009) M Varella-Garcia et al. JOURNAL OF CLINICAL PATHOLOGY
- Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non-Small Cell Lung Cancers
- (2009) E. Lin et al. MOLECULAR CANCER RESEARCH
- Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
- (2009) Helena Linardou et al. Nature Reviews Clinical Oncology
- EML4–ALK fusion transcript is not found in gastrointestinal and breast cancers
- (2008) Y Fukuyoshi et al. BRITISH JOURNAL OF CANCER
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- IncreasedEGFRGene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy
- (2008) Fred R. Hirsch et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical significance of p53 alterations in surgically treated prostate cancers
- (2008) Thorsten Schlomm et al. MODERN PATHOLOGY
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started